about
Genome-wide detection and characterization of positive selection in human populationsEmergence of Klebsiella pneumoniae carbapenemase-producing bacteriaA second generation human haplotype map of over 3.1 million SNPsInvestigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findingsClinical Findings of West Nile Virus Infection in Hospitalized Patients, New York and New Jersey, 2000Suicide prevention strategies: a systematic review.The standard one gram dose of vancomycin is not adequate prophylaxis for MRSAExtended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center.The Otto Aufranc Award: Modifiable versus nonmodifiable risk factors for infection after hip arthroplasty.Preventing surgical site infections: a randomized, open-label trial of nasal mupirocin ointment and nasal povidone-iodine solution.Central line-associated bloodstream infection surveillance outside the intensive care unit: a multicenter survey.Multidrug-resistant Acinetobacter baumannii in New York City - 10 years into the epidemic.Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infectionsAntibiotic stewardship for intra-abdominal infections: early impact on antimicrobial use and patient outcomes.Implementation and evaluation of an automated surveillance system to detect hospital outbreak.Preventing Infections in Children with Cancer.In vitro antiseptic effects on viability of neuronal and Schwann cells.World Trade Center rescue worker injury and illness surveillance, New York, 2001.Public health and environmental response to the first case of naturally acquired inhalational anthrax in the United States in 30 years: infection of a new york city resident who worked with dried animal hides.Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity.Mycobacterium chimaera left ventricular assist device infections.Prior Staphylococcus Aureus Nasal Colonization: A Risk Factor for Surgical Site Infections Following Decolonization.Engaging Frontline Staff in Central Line-Associated Bloodstream Infection Prevention Practice in the Wake of Superstorm Sandy.Single high dose gentamicin for perioperative prophylaxis in orthopedic surgery: Evaluation of nephrotoxicity.Expanded Gram-Negative Antimicrobial Prophylaxis Reduces Surgical Site Infections in Hip Arthroplasty.Risk Factors for Infection Following Total Knee Arthroplasty: A Series of 3836 Cases from One Institution.Comparison of two methods of documenting urinary and central venous catheters at an academic medical center.Is routine antibiotic prophylaxis cost effective for total joint replacement patients?Impact of preoperative MRSA screening and decolonization on hospital-acquired MRSA burden.Risk of hepatitis C virus exposure in orthopedic surgery: is universal screening needed?Evaluation of bloodborne pathogen exposures at an urban hospital.Incidence and risk factors for hospital-acquired Clostridium difficile infection among inpatients in an orthopaedic tertiary care hospital.A large outbreak of hepatitis B virus infections associated with frequent injections at a physician's office.Orthopedic surgical site infections: analysis of causative bacteria and implications for antibiotic stewardship.Permanent neurological deficit related to magnetic resonance imaging in a patient with implanted deep brain stimulation electrodes for Parkinson's disease: case report.Hepatitis C transmission due to contamination of multidose medication vials: summary of an outbreak and a call to action.Detection of volatile biomarkers of therapeutic radiation in breath.Epidemiology and burden of hepatitis A, malaria, and typhoid in New York City associated with travel: implications for public health policy.Initial Therapy for Mild to Moderate Clostridium difficile InfectionAuthors' reply
P50
Q23000444-34988F55-C044-4AF8-8FF4-E04D3F1E4F6FQ24618178-C1DFA9C1-0996-425C-8B2A-B8CE7DA359C2Q24651939-C0C50C9A-5B74-4AF5-AD44-D0D26D8D3F08Q24718884-6497E71E-2490-4454-99FA-5BC4E27367C8Q27487807-36EBD5F5-706E-4C7C-9EE3-9943287A103DQ33225970-B827EA0F-82BD-4765-B253-0BD7499D348EQ34024012-FFB87BD7-616A-4EBF-B05A-BBCC21F3F0E9Q34058137-61F74EE1-686D-4745-853C-92E6C97A36BEQ34962954-9271FB81-E821-49DD-B356-331DDA618C77Q36344588-276EE00F-B3B7-4CC3-BA4E-806AC826B193Q36895917-C4F757DB-F36B-4FC8-B5F7-3EA94297EB1DQ37013618-CC93DD40-6EDA-459C-9382-E1012DE2DABBQ37263364-BAD60BD5-464A-4172-B301-5D29CFF9DA0CQ37993725-801C26F0-4A1D-49F1-87EB-68D4B79D9390Q38606811-6D005478-2019-4716-99D3-9ECDF50240C4Q38851043-3817DA85-3F48-4D2F-83E5-3DE113DE7BAAQ39424373-68C083BC-EB5F-4532-88FC-9CB12D6A0B27Q39655864-CAAFC3A0-987D-4CF3-8CE1-875CAA09EDB8Q39886862-AF09F373-5BE5-4647-B4FF-53B45B0D3125Q40123070-5797A169-874A-4BD8-9353-78F23E1BFB0CQ40199925-E598700E-6EB5-4DDD-90C2-45395389907FQ40457453-D18F95E7-98E5-41B7-9324-50D9934AA4F8Q40504530-B1449CE6-949C-4145-9357-E453FD1E11C0Q40832109-62FC4D10-4110-4F3C-B142-EC12389434C3Q40928654-923914E3-510E-46BE-BB90-146DAD7A4CB8Q41102251-4E102C52-8179-4FFA-8591-B1D849C9B16CQ41480209-BE3D0197-614D-44B8-9157-2C08A253757EQ41611834-E0B4887D-59E6-4BA5-BF13-A72D1096DFBEQ42145640-8279D425-9418-427B-91D7-CC5E613D2649Q42211377-F18B4C15-2476-4F3B-9532-E233AF8B10B3Q43621153-08B77218-83B5-4A5F-9D7D-0DF6D0501FCBQ44638116-6E886315-42F0-4AC6-896B-FB4BF77AA938Q45423479-F36E42F1-68F4-4D73-BED5-D519C4B7F49FQ46892959-BC8A4A28-BF36-4AF2-AE4A-4E272A7ED95EQ48697717-13DA6D2B-51CF-4E83-99E8-164536257B84Q50756198-07C4C8C6-B6E6-4EA2-84AC-4B23ED7768F5Q51168812-4EAC756D-8E09-4547-A37A-52B7D5AD8804Q51851311-129F1E19-25C9-4979-A293-51E71F949CB1Q57274890-D5E7415B-206F-47AD-8C93-7A0B0D975DD9Q57274891-B1DEDE50-66A9-4705-B1DE-83B9613A21B7
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael S Phillips
@ast
Michael S Phillips
@en
Michael S Phillips
@es
Michael S Phillips
@sl
type
label
Michael S Phillips
@ast
Michael S Phillips
@en
Michael S Phillips
@es
Michael S Phillips
@sl
prefLabel
Michael S Phillips
@ast
Michael S Phillips
@en
Michael S Phillips
@es
Michael S Phillips
@sl
P106
P21
P31
P496
0000-0003-1040-9080